A new study from Johns Hopkins shows that commonly used
The study involved mice but researcher expect to launch clinical trials in humans with COPD, including chronic emphysema and bronchitis.
There are currently no treatments to prevent or repair lung damage in those with COPD, which now amounts to 12 million Americans. There are only treatments addressing symptoms such as shortness of breath, coughing and mucus production and surgery.
"Because these drugs are already approved for use in the United States as safe and effective treatments for hypertension, incorporating them into our treatment regimen for COPD would be quite rapid,” said the mice study senior investigator Dr. Enid Neptune. a Hopkins pulmonologist and an associate professor.